Two Sigma Investments LP Trims Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Two Sigma Investments LP reduced its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 48.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 154,413 shares of the company’s stock after selling 144,345 shares during the quarter. Two Sigma Investments LP owned 0.11% of AdaptHealth worth $1,470,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of AHCO. Principal Financial Group Inc. raised its position in AdaptHealth by 204.0% during the fourth quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company’s stock valued at $15,735,000 after acquiring an additional 1,109,021 shares in the last quarter. Segall Bryant & Hamill LLC raised its position in AdaptHealth by 29.8% during the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company’s stock valued at $45,734,000 after acquiring an additional 1,102,173 shares in the last quarter. Dimensional Fund Advisors LP raised its position in AdaptHealth by 17.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company’s stock valued at $32,174,000 after acquiring an additional 505,180 shares in the last quarter. Bridgeway Capital Management LLC raised its position in AdaptHealth by 27.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 1,324,043 shares of the company’s stock valued at $12,605,000 after acquiring an additional 283,143 shares in the last quarter. Finally, Royce & Associates LP raised its position in AdaptHealth by 29.0% during the fourth quarter. Royce & Associates LP now owns 1,002,755 shares of the company’s stock valued at $9,546,000 after acquiring an additional 225,350 shares in the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Royal Bank of Canada cut their price objective on AdaptHealth from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Thursday, May 8th. Robert W. Baird boosted their price objective on AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Canaccord Genuity Group boosted their price objective on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Truist Financial cut their price objective on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, May 12th. Finally, UBS Group cut their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $13.40.

AdaptHealth Stock Up 1.3%

Shares of NASDAQ:AHCO opened at $8.86 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The business has a fifty day moving average of $8.90 and a two-hundred day moving average of $9.58. The stock has a market cap of $1.20 billion, a P/E ratio of -5.37, a PEG ratio of 1.08 and a beta of 1.64. AdaptHealth Corp. has a 52-week low of $7.11 and a 52-week high of $11.90.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.